Suchergebnisse - "Santoni, Matteo"

PubPharm (553)

1

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

2

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

enthalten in: Cancer immunology immunotherapy | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

3

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

enthalten in: Clinical & experimental metastasis | 2024

von Maffezzoli, M. | Santoni, M. | Mazzaschi, G. | +24

4

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Leonetti, A. | Perrone, F. | Puntoni, M. | +43

5

Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma : A systematic review and network meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2024

von Monteiro, F. | Soares, A. | Mollica, V. | +8

6

Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma : Insights From the ARON-1 Study

enthalten in: Clinical genitourinary cancer | 2024

von Monteiro, F. | Fiala, O. | Massari, F. | +17

7

Papillary Renal Cell Carcinoma : Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study

enthalten in: European urology oncology | 2024

von Massari, F. | Mollica, V. | Fiala, O. | +21

8

Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib

enthalten in: Clinical genitourinary cancer | 2024

von Catalano, M. | De Giorgi, U. | Bimbatti, D. | +9

9

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

enthalten in: Clinical & experimental metastasis | 2024

von Maffezzoli, M. | Santoni, M. | Mazzaschi, G. | +24

10

Pembrolizumab plus enfortumab vedotin in urothelial cancer

enthalten in: Nature reviews. Urology | 2024

von Santoni, M. | Takeshita, H. | Massari, F. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[56]